Home 2023
Archives
Glutamate excitotoxicity in the cochlea
Mark Rutherford, Associate Professor at Washington University School of Medicine, discusses the burden and causes of hearing dysfunction, as well as the possible solutions for mitigating glutamate excitotoxicity.
The role of microbial diversity in microbial electrosynthesis
Bacteria are often painted as the enemy of humanity. Before the discovery of antibiotics, a wound getting infected was frequently a death sentence.
Using psychedelics to mitigate Treatment Resistant Depression
Cosmo Feilding-Mellen, CEO, Beckley Psytech, charts the role of psychedelics in mitigating Treatment Resistant Depression.
Exploring neurological & mental brain disorders in Europe
European Brain Council provides a very helpful update on Brain disorders in Europe – neurological and mental alike.
Sight loss research: Looking forward to an equitable future
Keith Valentine, Chief Executive of Fight for Sight and Vision Foundation, shares how these newly merged organisations are driving efforts in sight loss research to improve patient care.
Keep your teeth for life, but how?
Drs Marcel Donnet and Neha Dixit discuss the importance of teeth cleaning and how the innovative AIRFLOW® PLUS powder can tackle biofilm and safeguard oral health.
Improving AI/ML services for ophthalmology and medicine
Eric Buckland, PhD of Translational Imaging Innovations, delves into how we can achieve better transparency, traceability, and reproducibility in AI/ML for ophthalmology and medicine.
Exploring the effects of medical cannabis for chronic pain
Dr Simon Erridge of Sapphire Medical Clinics discusses the therapeutic effects of medical cannabis for chronic pain, affecting 15.5 million people in England and why more evidence is needed to support greater patient access.
Understanding immune mechanisms to create novel treatments for primary biliary cholangitis
Professor Channakeshava S Umeshappa from Dalhousie University discusses the burden of primary biliary cholangitis and how understanding immune mechanisms may help to treat it.
CB2R agonists in the clinics: A treasure chest for treating inflammatory diseases
Researchers give an update on clinical trials with CB2R agonists and their potential for the treatment of inflammatory diseases.
Clinical trial challenges for new technology in radiation oncology
Stephen Kry, Professor from the University of Texas MD Anderson Cancer Center, explores clinical trial challenges for new technology in radiation oncology, including the radiotherapy treatment technique, proton therapy.
Knee pain and osteoarthritis (Knee OA) treatment research
Professor Shaw-Ruey Lyu from the School of Medicine, Tzu-Chi University, discusses Knee Pain and Osteoarthritis (Knee OA) Treatment Research, in particular Knee Health Promotion Option (KHPO).
First international meeting towards eliminating paralysis after aortic aneurysm surgery
Professor Hamdy Awad, MD, FASA, from the Ohio State University Wexner Medical Center, examines the dangers of aortic aneurysm surgery and the importance of continued research towards eliminating paralysis.
Psychedelic therapies: The case for a new focus in the EU’s mental health care...
Tadeusz Hawrot, Founder and Executive Director of PAREA, states the case for a new focus in the EU’s mental health care approach, that is the underserved area of psychedelic therapies.
Transforming clinical capacity to be a force for good
Elina Naydenova, CEO of Feebris, shares her thoughts on how to improve the NHS clinical capacity, to serve more patients with enhanced healthcare technologies.
Nutritional management of chronic kidney disease in pets
Renea Creech and Kim Wilson outline the challenges of Chronic Kidney Disease in pets, the irreversible loss of kidney function, and how nutrition can help.
Analysing the effects of using cannabis on youth mental health
Mary Cannon, Professor of Psychiatric Epidemiology and Youth Mental Health at RCSI University of Medicine and Health Sciences, investigates the effects of using cannabis on young people’s mental health.
Opioid use for chronic pain: Part 2
Norm Buckley and Jason Busse from the Michael G. DeGroote Institute for Pain Research & Care in Canada probe the effectiveness of opioid use in Canada as a treatment for chronic noncancer pain.
Development of a new gene therapy drug as a treatment for hypophosphatasia
The current primary treatment for hypophosphatasia is enzyme replacement therapy; however the development of a new gene therapy drug, ARU-2801, may change the landscape forever.
Understanding age-related macular degeneration
Tunde Peto, Professor of Clinical Ophthalmology at Queen’s University Belfast, describes the symptoms, causes and treatments for age-related macular degeneration and how the prevalence of the disease could be reduced.